INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 428m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought PRAX

Self · Praxis Precision Medicines, Inc. · Praxis Precision Medicines, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Sep 29, 2026
Disclosed
Oct 12, 2026
Disclosure timeline13 days from execution to publication · legal deadline 45 days
Sep 29 executedOct 12, 2026 disclosed

PRAX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 13 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · PRAX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    28
    Gilbert Ray Cisneros, Jr.DSelf
    PRAXPraxis Precision Medicines, Inc.
    Purchase
    		BUY$1,001 – $15KJul 30, 2026Sep 4, 2026
    traded Jul 30, 2026
    		+36dHOUSE PTR

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$403K
    1,279 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$890K
    2,854 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$314K
    1,004 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$158K
    504 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$264K
    837 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    17
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$379K
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    13
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$447K
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3,014
    10 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$36K
    120 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    8
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$98K
    320 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$210K
    683 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$382K
    1,240 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$309K
    999 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$544K
    1,750 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    NA
    Nemiroff AlexGeneral Counsel and Secretary
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$212K
    768 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    12
    ML
    Mastrocola LaurenPrincipal Accounting Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$95K
    344 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    12
    SM
    Sniecinski MeganChief Operating Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$244K
    885 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035622

    Timestamps

    Event (reported)
    Sep 29, 2026
    Published
    Oct 12, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 6, 09:19 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    Praxis Precision Medicines, Inc. - Common Stock
    Ticker
    PRAX
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Sep 29, 2026
    Notification date (reported)
    Oct 9, 2026
    Days from execution to publication
    13

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of Praxis Precision Medicines, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    Praxis Precision Medicines, Inc.cik:0001689548

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.